A randomized, placebo‐ and active‐controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

H.F. Chang, Ping‐Tao Tseng, Brendon Stubbs, Che‐Sheng Chu, Dian‐Jeng Li, Michele Fornaro, André F. Carvalho, Marco Solmi, Nicola Veronese, Eduard Vieta, Tien‐Yu Chen, Yen‐Wen Chen, Pao‐Yen Lin, Philip C. Chow

Article2008

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

Charles L. Bowden, Ahmet Göğüş, Heinz Grunze, Lars Häggström, Janusz Rybakowski, Eduard Vieta

Article2007

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

Lakshmi N. Yatham, Eduard Vieta, Allan H. Young, Hans‐Jürgen Möller, Björn Paulsson, Mårten Vågerö

A randomized, placebo‐ and active‐controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

Abstract

Discussion(0)

Related publications

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study

P.2.e.018 Randomized, placebo, active-controlled study of paliperidone extended-release (ER) for acute manic and mixed episodes in bipolar I disorder

The efficacy and tolerability of paliperidone in mania of bipolar disorder: A preliminary meta-analysis.

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania